Cyclic GMP in sequential samples of lumbar CSF in man

[1]  S. Gauthier,et al.  Effect of oral melatonin administration on melatonin, 5-hydroxyindoleacetic acid, indoleacetic acid, and cyclic nucleotides in human cerebrospinal fluid. , 1984, Neuroendocrinology.

[2]  H. Cramer,et al.  Cyclic nucleotides in cerebrospinal fluid of patients with intracranial and spinal tumors , 1982, Acta neurologica Scandinavica.

[3]  G. Catravas,et al.  Cerebrospinal fluid cyclic nucleotides and GABA do not change in alcohol withdrawal. , 1981, Life sciences.

[4]  B. Shanley,et al.  Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations , 1980, British Journal of Psychiatry.

[5]  S. Otsuki,et al.  Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. , 1979, Biological psychiatry.

[6]  R. Ebstein,et al.  Clinical correlates of CSF cyclic nucleotides in schizophrenia. , 1978, The American journal of psychiatry.

[7]  D. Taylor,et al.  Microiontophoretic studies of the effects of cyclic nucleotides on excitability of neurones in the rat cerebral cortex , 1977, The Journal of physiology.

[8]  R. Post,et al.  An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients. , 1976, Life sciences.

[9]  D. Rudman,et al.  Observations on the cyclic nucleotide concentrations in human cerebrospinal fluid. , 1976, The Journal of clinical endocrinology and metabolism.

[10]  G. C. Palmer,et al.  Regional cyclic GMP content in incubated tissue slices of rat brain. , 1975, European journal of pharmacology.

[11]  P. Greengard,et al.  Muscarinic cholinergic regulation of cyclic guanosine 3,5-monophosphate in autonomic ganglia: possible role in synaptic transmission. , 1975, The Journal of pharmacology and experimental therapeutics.

[12]  S. Young,et al.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. , 1974, Brain research.

[13]  D. Janowsky,et al.  Parasympathetic suppression of manic symptoms by physostigmine. , 1973, Archives of general psychiatry.

[14]  P. Greengard,et al.  Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain. , 1972, The Journal of biological chemistry.

[15]  J. Ferrendelli,et al.  The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellum. , 1970, Biochemical and biophysical research communications.

[16]  R. Ebstein,et al.  Cyclic nucleotides in mental disorder. , 1980, Advances in cyclic nucleotide research.

[17]  W. Engel,et al.  Extracellular Cyclic Nucleotide Metabolism in the Human Central Nervous System , 1980 .

[18]  John Daly,et al.  Cyclic Nucleotides in the Nervous System , 1977, Springer US.

[19]  D. Kipnis,et al.  The measurement of cyclic nucleotides by radioimmunoassay. , 1970, Advances in biochemical psychopharmacology.